Skye Bioscience, Inc. Common Stock Capital Reinvestment Ratio

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock capital reinvestment ratio. Skye Bioscience, Inc. Common Stock (SKYE) has a Capital Reinvestment Ratio of 8.56x as of June 2014, meaning it reinvests 9% of its operating cash flow ($7.92K) in capital expenditures ($67.83K). Check Skye Bioscience, Inc. Common Stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

8.56x

Capex / Operating Cash Flow

Operating Cash Flow

$7.92K

USD

Capital Expenditures

$67.83K

USD

Data as of

Jun 2014

Most recent filing

Skye Bioscience, Inc. Common Stock Capital Reinvestment Ratio by Year (None–None)

Skye Bioscience, Inc. Common Stock capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Skye Bioscience, Inc. Common Stock cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow